The counter regulatory response induced by CpG oligonucleotides prevents bleomycin induced pneumopathy
<p>Abstract</p> <p>Bleomycin (BLM) induces life-threatening pneumonitis and pulmonary fibrosis in 20% of patients, limiting its use as a chemotherapeutic agent. Oligonucleotides expressing immunostimulatory CpG motifs (CpG ODN) stimulate cells that express Toll-like receptor 9 to i...
Main Authors: | Kinjo Takeshi, Tomaru Koji, Haines Diana C, Klinman Dennis M |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-06-01
|
Series: | Respiratory Research |
Subjects: | |
Online Access: | http://respiratory-research.com/content/13/1/47 |
Similar Items
-
The Study of the Therapeutic Effects of CpG Oligonucleotides in Murine Model of Allergic Asthma
by: T. Mousavi, et al.
Published: (2007-07-01) -
CpG Oligonucleotides as Cancer Vaccine Adjuvants
by: Hidekazu Shirota, et al.
Published: (2015-05-01) -
Nanoparticle System Based on Amino-Dextran as a Drug Delivery Vehicle: Immune-Stimulatory CpG-Oligonucleotide Loading and Delivery
by: Hien V. Nguyen, et al.
Published: (2020-11-01) -
Synthetic Hexanucleotides as a Tool to Overcome Excessive Neutrophil Activation Caused by CpG-Containing Oligonucleotides
by: Ekaterina A. Golenkina, et al.
Published: (2021-04-01) -
Adjuvant Activity of CpG-Oligonucleotide Administered Transcutaneously in Combination with Vaccination Using a Self-Dissolving Microneedle Patch in Mice
by: Sachiko Hirobe, et al.
Published: (2021-12-01)